Dectova

Dectova (Zanamivir) is an antiviral medication used to treat influenza. It works by stopping the virus from spreading in the body. This intravenous formulation is manufactured by GlaxoSmithKline Trading Services Limited.

Dectova is primarily used for the treatment of influenza, commonly known as the flu. It is designed to help reduce the severity and duration of flu symptoms. Zanamivir, the active ingredient, is often prescribed for individuals who have been diagnosed with influenza and are at risk of complications.

Common effects of Dectova may include respiratory issues such as bronchospasm, especially in patients with underlying lung conditions. Some individuals may also experience symptoms like headache, dizziness, and nausea. It is important to monitor for any adverse reactions and consult a healthcare provider if they occur.

Dectova should be used with caution in patients with a history of respiratory problems. It is essential to follow the prescribed dosage and administration instructions carefully. Patients should inform their healthcare provider about any pre-existing conditions or allergies before starting treatment.

Dectova may interact with other medications, particularly those that affect the respiratory system. It is advisable to avoid using Zanamivir in combination with other antiviral drugs without medical supervision. Always consult a healthcare provider to ensure safe and effective use.